Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species.
about
Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cellsBimolecular fluorescence complementation analysis of eukaryotic fusion products.Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.Chemotherapy and dietary phytochemical agents.Ionizing radiation-induced responses in human cells with differing TP53 status.A systematic approach to cancer: evolution beyond selectionThe shock of being united and symphiliosis. Another lesson from plants?
P2860
Q33900760-43655718-9DAA-479D-8646-85A94589E9F3Q34052041-678F611E-2823-4699-9DC1-D378C9BA5DF3Q34658230-A74B6ABC-968E-4C74-A6CD-C8EDDB148A78Q36516033-CA6157F4-070D-4610-B502-7A1DC00D863BQ38162722-1947D809-DD8B-49E6-B121-45B5BD63875DQ40629103-266BD688-DB3A-411A-B29D-5916434C8080Q41918920-ECCAAB43-7576-462F-9BF7-264497AF7FDA
P2860
Clinically significant cancer evolves from transient mutated and/or aneuploid neoplasia by cell fusion to form unstable syncytia that give rise to ecologically viable parasite species.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinically significant cancer ...... cally viable parasite species.
@en
type
label
Clinically significant cancer ...... cally viable parasite species.
@en
prefLabel
Clinically significant cancer ...... cally viable parasite species.
@en
P1433
P1476
Clinically significant cancer ...... cally viable parasite species.
@en
P2093
George E Parris
P304
P356
10.1016/J.MEHY.2005.05.036
P577
2005-01-01T00:00:00Z